MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12893-021-01137-y

Медицинская библиотека · BMC surgery · 2021

COVID-19 outbreak and acute cholecystitis in a Hub Hospital in Milan: wider indications for percutaneous cholecystostomy.

Barabino Matteo, Piccolo Gaetano, Trizzino Arianna, Fedele Veronica, Ferrari Carlo, Nicastro Vincenzo, Pisani Ceretti Andrea, De Nicola Enrico, Mariani Nicolò Maria, Giovenzana Marco, Scifo Giovanna, Mazza Massimiliano, Vercelli Ruggero, Santambrogio Roberto, Luigiano Carmelo, Opocher Enrico

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

COVID-19 pandemic has impacted the Italian National Health Care system at many different levels, causing a complete reorganization of surgical wards. In this context, our study retrospectively analysed the management strategy for patients with acute cholecystitis.

METHODS

We analysed all patients admitted to our Emergency Department for acute cholecystitis between February and April 2020 and we graded each case according to 2018 Tokyo Guidelines. All patients were tested for positivity to SARS-CoV-2 and received an initial conservative treatment. We focused on patients submitted to cholecystostomy during the acute phase of pandemic and their subsequent disease evolution.

RESULTS

Thirty-seven patients were admitted for acute cholecystitis (13 grade I, 16 grade II, 8 grade III). According to Tokyo Guidelines (2018), patients were successfully treated with antibiotic only, bedside percutaneous transhepatic gallbladder drainage (PC) and laparoscopic cholecystectomy (LC) in 29.7%, 21.6% and 48.7% of cases respectively. Therapeutic strategy of three out of 8 cases, otherwise fit for surgery, submitted to bedside percutaneous transhepatic gallbladder drainage (37.5%), were directly modified by COVID-19 pandemic: one due to the SARS-CoV-2 positivity, while two others due to unavailability of operating room and intensive care unit for post-operative monitoring respectively. Overall success rate of percutaneous cholecystostomy was of 87.5%. The mean post-procedural hospitalization length was 9 days, and no related adverse events were observed apart from transient parietal bleeding, conservatively treated. Once discharged, two patients required readmission because of acute biliary symptoms. Median time of drainage removal was 43 days and only 50% patients thereafter underwent cholecystectomy.

CONCLUSIONS

Percutaneous cholecystostomy has shown to be an effective and safe treatment thus acquiring an increased relevance in the first phase of the pandemic. Nowadays, considering we are forced to live with the SARS-CoV-2 virus, PC should be considered as a virtuous, alternative tool for potentially all COVID-19 positive patients and selectively for negative cases unresponsive to conservative therapy and unfit for surgery.

Для цитирования: Barabino Matteo, Piccolo Gaetano, Trizzino Arianna, Fedele Veronica, Ferrari Carlo, Nicastro Vincenzo, Pisani Ceretti Andrea, De Nicola Enrico, Mariani Nicolò Maria, Giovenzana Marco, Scifo Giovanna, Mazza Massimiliano, Vercelli Ruggero, Santambrogio Roberto, Luigiano Carmelo, Opocher Enrico. COVID-19 outbreak and acute cholecystitis in a Hub Hospital in Milan: wider indications for percutaneous cholecystostomy.. BMC surgery. 2021. DOI: 10.1186/s12893-021-01137-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.